This retrospective cohort study describes causes of death in 305 patients (baseline median CD4 count 26/μl) from 2 943 adults on antiretroviral therapy. Acute sepsis (20%), tuberculosis (18%) and Mycobacterium avium complex (MAC) bacteraemia (14%) were the most common causes. Mortality owing to the disease was 66% for MAC bacteraemia and 23% for non-Hodgkin’s lymphoma. In 37 patients dying beyond one year on ART, virological failure was present in 11 (30%), and non-HIV-related causes of death occurred in 10. The main causes were acute sepsis (6), tuberculosis (7) and chronic medical conditions (5). Initiating ART at higher CD4 counts should reduce early mortality
Introduction: This study sought to identify common causes of death as well as the factors associated...
BackgroundWe report trends in mortality patterns and causes among HIV positive patients, who initiat...
Since launching of antiretroviral (ART) treatment, the numbers of patients enrolled in to ART are in...
Mortality in the first months of antiretroviral therapy (ART) is a significant clinical problem in s...
Mortality in the first months of antiretroviral therapy (ART) is a significant clinical problem in s...
Abstract Background The roll out of antiretroviral therapy (ART) in Sub-Saharan Africa led to a decr...
BACKGROUND: There have been few reports of long-term survival of HIV-infected patients on antiretrov...
In sub-Saharan Africa, early mortality is high following initiation of antiretroviral therapy (ART)....
In sub-Saharan Africa, early mortality is high following initiation of antiretroviral therapy (ART)....
OBJECTIVES: To determine rates, risk factors and causes of death among patients accessing a communit...
Background: Causes of death related studies in HIV infected population are necessary to devise disea...
BACKGROUND: In sub-Saharan Africa, early mortality is high following initiation of antiretroviral th...
Objectives: To evaluate survival and investigate causes of death among HIV-1 infected adults receivi...
Objective: To determine risk factors for death in HIV-infected African patients on anti-retroviral t...
Two-thirds of the world's HIV-infected people live in sub-Saharan Africa, and more than 1.5 million ...
Introduction: This study sought to identify common causes of death as well as the factors associated...
BackgroundWe report trends in mortality patterns and causes among HIV positive patients, who initiat...
Since launching of antiretroviral (ART) treatment, the numbers of patients enrolled in to ART are in...
Mortality in the first months of antiretroviral therapy (ART) is a significant clinical problem in s...
Mortality in the first months of antiretroviral therapy (ART) is a significant clinical problem in s...
Abstract Background The roll out of antiretroviral therapy (ART) in Sub-Saharan Africa led to a decr...
BACKGROUND: There have been few reports of long-term survival of HIV-infected patients on antiretrov...
In sub-Saharan Africa, early mortality is high following initiation of antiretroviral therapy (ART)....
In sub-Saharan Africa, early mortality is high following initiation of antiretroviral therapy (ART)....
OBJECTIVES: To determine rates, risk factors and causes of death among patients accessing a communit...
Background: Causes of death related studies in HIV infected population are necessary to devise disea...
BACKGROUND: In sub-Saharan Africa, early mortality is high following initiation of antiretroviral th...
Objectives: To evaluate survival and investigate causes of death among HIV-1 infected adults receivi...
Objective: To determine risk factors for death in HIV-infected African patients on anti-retroviral t...
Two-thirds of the world's HIV-infected people live in sub-Saharan Africa, and more than 1.5 million ...
Introduction: This study sought to identify common causes of death as well as the factors associated...
BackgroundWe report trends in mortality patterns and causes among HIV positive patients, who initiat...
Since launching of antiretroviral (ART) treatment, the numbers of patients enrolled in to ART are in...